Skip to content

Construction of a Novel Analytical Method Based on Global Serum Differences and Its Application and Mechanism Exploration in Liver Cirrhosis Assessment

Construction of a Novel Analytical Method Based on Global Serum Differences and Its Application and Mechanism Exploration in Liver Cirrhosis Assessment

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600117765
Enrollment
Unknown
Registered
2026-01-28
Start date
2024-01-03
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Fibrosis

Interventions

Gold Standard:Gold standard: liver cirrhosis (liver fibrosis) confirmed by liver biopsy.
Index test:Based on the morphology of uric acid crystal growth and droplet drying, a large number of crystal and droplet images were obtained and an image database was established. By combining AI to

Sponsors

Southern Medical University Southern Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Patients with liver cirrhosis: (1) Voluntary provision of written informed consent; (2) Age 18–75 years; (3) Attended Nanfang Hospital, Southern Medical University, on or before December 2025; (4) Diagnosed with liver cirrhosis based on the patient’s presenting complaints, medication history, and relevant laboratory test results. 2.Healthy control population: (1) Voluntary provision of written informed consent; (2) Aged 18–75 years; (3) Health examination, no underlying diseases, and the examination index is within the normal range of health examination population.

Exclusion criteria

Exclusion criteria: 1.Patients with liver cirrhosis: (1) Presence of comorbid conditions such as malignant tumors, acute myocardial infarction, post-stroke sequelae, coronary artery bypass grafting (CABG), benign brain tumors, bilateral deafness (at specified ages), paralysis, bilateral blindness (at specified ages), heart valve surgery, severe brain injury, third-degree burns, loss of speech/language function, aortic surgery, myasthenia gravis, and severe rheumatoid arthritis, among others. No other major systemic diseases; no recent major surgery or major medical interventions; not pregnant or breastfeeding; (2) Severe hemolysis or lipemia in serum samples; (3) Deemed unsuitable for participation in this study by the investigator. 2.Healthy control population: (1) Severe hemolysis or lipemia in serum samples; (2) Deemed unsuitable for participation in this study by the investigator.

Design outcomes

Primary

MeasureTime frame
Sensitivity;Specificity;negative predictive value, NPV;positive predictive value, PPV;Receiver Operating Characteristic Curve, ROC;Accuracy;

Countries

China

Contacts

Public ContactSitu Bo

Southern Medical University Southern Hospital

drstb@126.com+86 20 61641044

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026